Skip to main content
CVRX
NASDAQ Life Sciences

Hagens Berman Opens Securities Fraud Probe Into CVRx After 59% Plunge

Tom Rudovsky · Reported by PR Newswire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$3.13
Mkt Cap
$83.388M
52W Low
$2.2
52W High
$11.3
52W Position info
42% above low
Off High info
72% below high
Rel. Volume info
2.6× avg
Market data snapshot near publication time

CVRX sits 42% above its 52-week low of $2.2 on elevated volume (2.6× avg).

Summary

Hagens Berman, a national securities law firm, announced an investigation into CVRx for potential securities fraud. The probe follows the company's August 6 disclosures of a DOJ Civil Investigative Demand, severe revenue guidance cuts, sales force disruption, and a collapse in Medicare Advantage approval rates from 80% to 25% within 30 days. The stock fell 59% on August 7. The firm is also examining whether the August 10 termination of Chief Revenue Officer Robert John is connected to the DOJ inquiry. This adds a new legal overhang to an already battered stock, and the investigation could lead to a class action lawsuit. The DOJ CID and the abrupt CRO departure suggest deeper operational and compliance issues than previously disclosed.

At the time of this announcement, CVRX was trading at $3.13 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $83.4M. The 52-week trading range was $2.20 to $11.30. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: PR Newswire.


Price Chart

Share this article

Copied!

CVRX - Latest Insights

CVRX
Nov 05, 2026, 4:17 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.47
Real-time Price: $0.6641 info
Change: -$0.8059 (-55%) info
Market Cap: $18.589M info
CVRX
Nov 05, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.47
Real-time Price: $0.6641 info
Change: -$0.8059 (-55%) info
Market Cap: $18.589M info
CVRX
Nov 05, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.47
Real-time Price: $0.6641 info
Change: -$0.8059 (-55%) info
Market Cap: $18.589M info
CVRX
Oct 02, 2026, 9:30 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
8
Price at Filing: $1.53
Real-time Price: $0.6641 info
Change: -$0.8659 (-57%) info
Market Cap: $18.589M info
CVRX
Sep 21, 2026, 4:13 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $2.97
Real-time Price: $0.6641 info
Change: -$2.31 (-78%) info
Market Cap: $18.589M info